These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19810168)

  • 1. A comparison of the in-vitro properties of ceftazidime with those of new broad-spectrum cephalosporins and gentamicin.
    Harris AM; Plested SJ; Harper PB
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():43-5. PubMed ID: 19810168
    [No Abstract]   [Full Text] [Related]  

  • 2. Ceftazidime, a pseudomonas-active cephalosporin: in-vitro antimicrobial activity evaluation including recommendations for disc diffusion susceptibility tests.
    Jones RN; Barry AL; Thornsberry C; Gerlach EH; Fuchs PC; Gavan TL; Sommers HM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():187-211. PubMed ID: 19802985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility of ceftazidime and other cephalosporins to a range of beta-lactamases and their potential as inducing agents.
    Mouton RP; Bongaerts GP; van Gestel MH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():147-52. PubMed ID: 19802978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the activity of cephalosporins against Pseudomonas aeruginosa.
    Bauernfeind A
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():111-7. PubMed ID: 19810172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in-vivo antibacterial activity of ceftazidime (Gr 20263)--a comparison with other new beta-lactam antibiotics and gentamicin.
    Acred P; Ryan DM; Sowa MA; Watts CM
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():247-55. PubMed ID: 19802994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behaviour of ceftazidime towards beta-lactamases.
    Labia R; Beguin-Billecoq R; Guionie M
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():141-6. PubMed ID: 19810176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin.
    Chin NX; Neu HC
    Chemioterapia; 1986 Apr; 5(2):92-100. PubMed ID: 3518967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in-vitro activity of ceftazidime (GR-20263) and other beta-lactamase stable cephalosporins against anaerobic bacteria.
    Chow AW; Bartlett KH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():91-5. PubMed ID: 19802974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in-vitro activity of three anti-pseudomonal cephalosporins against isolates from patients with cystic fibrosis.
    Kelly N; Falkiner FR; Keane CT; Murphy M; Fitzgerald MX
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():175-8. PubMed ID: 19802982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefditoren versus ceftazidime in inducer-substrate combinations for the evaluation of AmpC production in a disc approximation test.
    Cafini F; Aguilar L; Alou L; Giménez MJ; Sevillano D; Torrico M; González N; Coronel P; Prieto J
    Rev Esp Quimioter; 2010 Jun; 23(2):72-5. PubMed ID: 20559604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The in-vitro properties of ceftazidime.
    Harper PB
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():5-13. PubMed ID: 19802965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vitro activity of ceftazidime, a beta-lactamase stable cephalosporin.
    Neu HC
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():131-4. PubMed ID: 19810175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of ceftazidime and N-formimidoyl thienamycin against gentamicin-susceptible and resistant Pseudomonas aeruginosa.
    Alford RH
    J Antimicrob Chemother; 1983 Jun; 11(6):599-601. PubMed ID: 6411675
    [No Abstract]   [Full Text] [Related]  

  • 14. Ro 13-9904 and GR 20263, two new cephalosporins with broad-spectrum activity: an in vitro comparison with other beta-lactam antibiotics.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1981 May; 7(5):515-20. PubMed ID: 6790506
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro activity of piperacillin and other microbials on 491 bacterial isolates.
    Reeves DS
    Arch Intern Med; 1982 Oct; 142(11):2023-32. PubMed ID: 6215009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of ceftazidime against Pseudomonas aeruginosa: and its stability to pseudomonal beta-lactamases.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():163-7. PubMed ID: 19802980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ceftazidime, gentamicin, and rifampicin, in combination, kill biofilms of mucoid Pseudomonas aeruginosa.
    Ghani M; Soothill JS
    Can J Microbiol; 1997 Nov; 43(11):999-1004. PubMed ID: 9436304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in-vitro activity of ceftazidime (GR 20263) and other beta-lactamase stable cephalosporins against pseudomonas. Effect of inoculum size and divalent cation supplementation.
    Chow AW; Bartlett KH
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():345-8. PubMed ID: 19803012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of cefepime on ceftazidime, cefotaxime and imipenem resistant strains of Acinetobacter, Xanthomonas, Pseudomonas, Flavobacterium, Sphingobacterium and on producers of extended spectrum beta-lactamases (ESBL) with resistance transfer].
    Blahová J; Hupková-Lesická M; Králiková K; Krcméry V; Kubonová K
    Cas Lek Cesk; 1997 Mar; 136(5):154-6. PubMed ID: 9221190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibilities of gentamicin-resistant Gram-negative aerobic bacilli to cefotetan and other beta-lactams.
    Hart CA; Percival A
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():95-101. PubMed ID: 6573329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.